Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT00129168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid

Interventions

DRUG: Zosuquidar
DRUG: Daunorubicin
DRUG: Cytarabine

Sponsor

Kanisa Pharmaceuticals